In an early report, the expression of each ErbB family member was significantly associated with shortened survival in patients with oral HNSCC, but the co-expression of EGFR, ErbB2 and ErbB3 had an improved predicting power (93). This evidence concerns the gene ERBB2 and head and neck squamous cell carcinoma.